Krishna Undela

1.4k total citations
48 papers, 865 citations indexed

About

Krishna Undela is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Krishna Undela has authored 48 papers receiving a total of 865 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Krishna Undela's work include Lipoproteins and Cardiovascular Health (6 papers), Antibiotic Use and Resistance (6 papers) and Cancer, Lipids, and Metabolism (5 papers). Krishna Undela is often cited by papers focused on Lipoproteins and Cardiovascular Health (6 papers), Antibiotic Use and Resistance (6 papers) and Cancer, Lipids, and Metabolism (5 papers). Krishna Undela collaborates with scholars based in India, Canada and Australia. Krishna Undela's co-authors include Dipika Bansal, Sanjay D’Cruz, Fabrizio Schifano, Pramil Tiwari, Anil Bhansali, Kayleigh M Kew, Giovanni Ferrara, Muhammed Rashid, Kapil Gudala and Sai Krishna Gudi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cochrane Database of Systematic Reviews.

In The Last Decade

Krishna Undela

42 papers receiving 837 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Krishna Undela India 15 328 263 252 214 139 48 865
Prudence R. Carr Germany 17 109 0.3× 183 0.7× 123 0.5× 165 0.8× 423 3.0× 42 1.0k
Ling Jiang China 19 98 0.3× 104 0.4× 113 0.4× 263 1.2× 152 1.1× 93 1.0k
Iliana C. Lega Canada 17 139 0.4× 100 0.4× 149 0.6× 475 2.2× 328 2.4× 49 1.1k
Fernando Martínez Martínez Spain 17 129 0.4× 103 0.4× 73 0.3× 252 1.2× 84 0.6× 73 1.0k
Benjamin Daniels Australia 18 112 0.3× 101 0.4× 82 0.3× 364 1.7× 230 1.7× 76 1.3k
Sean M. Ronnekleiv‐Kelly United States 21 241 0.7× 311 1.2× 462 1.8× 371 1.7× 524 3.8× 62 1.5k
Crystal N. Holick United States 21 202 0.6× 260 1.0× 169 0.7× 314 1.5× 687 4.9× 38 1.8k
John Michael Gaziano United States 17 112 0.3× 48 0.2× 149 0.6× 206 1.0× 239 1.7× 49 866
Michiko Sugiyama Japan 14 198 0.6× 76 0.3× 207 0.8× 574 2.7× 367 2.6× 47 1.1k
Vincenzo Favilla Italy 25 72 0.2× 396 1.5× 197 0.8× 189 0.9× 73 0.5× 71 1.4k

Countries citing papers authored by Krishna Undela

Since Specialization
Citations

This map shows the geographic impact of Krishna Undela's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Krishna Undela with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Krishna Undela more than expected).

Fields of papers citing papers by Krishna Undela

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Krishna Undela. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Krishna Undela. The network helps show where Krishna Undela may publish in the future.

Co-authorship network of co-authors of Krishna Undela

This figure shows the co-authorship network connecting the top 25 collaborators of Krishna Undela. A scholar is included among the top collaborators of Krishna Undela based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Krishna Undela. Krishna Undela is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Undela, Krishna, et al.. (2026). Safety of immune checkpoint inhibitors: A systematic review of disproportionality analysis studies. European Journal of Clinical Pharmacology. 82(2). 35–35.
2.
Undela, Krishna, et al.. (2025). Efficacy and safety of capecitabine therapy in patients with Biliary tract cancer: A systematic review and meta-analysis. Journal of Oncology Pharmacy Practice. 3222406474–3222406474. 1 indexed citations
3.
4.
5.
Undela, Krishna, et al.. (2024). Efficacy and safety of luseogliflozin in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Endocrine. 86(2). 620–630. 1 indexed citations
6.
Thomas, Levin, et al.. (2024). Characteristics of isoniazid-induced psychosis: a systematic review of case reports and case series. European Journal of Clinical Pharmacology. 80(11). 1725–1740. 2 indexed citations
7.
8.
Ramesh, Madhan, et al.. (2022). Antifungal therapy in the management of fungal secondary infections in COVID-19 patients: A systematic review and meta-analysis. PLoS ONE. 17(7). e0271795–e0271795. 7 indexed citations
9.
10.
11.
Undela, Krishna, et al.. (2020). Knowledge and Beliefs of General Public of India on COVID-19: A Cross-sectional Survey. 2(5). 186–192. 1 indexed citations
12.
Undela, Krishna, et al.. (2020). Knowledge, beliefs, and practice of pregnant women regarding medication use during pregnancy: a hospital-based cross-sectional study. Journal of Obstetrics and Gynaecology. 41(4). 522–526. 5 indexed citations
13.
Rashid, Muhammed, et al.. (2019). Valproic acid and Stevens‐Johnson syndrome: a systematic review of descriptive studies. International Journal of Dermatology. 58(9). 1014–1022. 23 indexed citations
14.
Ramesh, Madhan, et al.. (2016). Assessment of impact of pharmacophilia and pharmacophobia on medication adherence in patients with psychiatric disorders: A cross-sectional study. Indian Journal of Pharmacology. 48(6). 701–701. 6 indexed citations
15.
Ramesh, Madhan, et al.. (2016). Cost Implications Of Inappropriate Prescribing Of Anti-Malarial Therapy For Treatment Of Undifferentiated Febrile Illness Among Elderly. Value in Health. 19(7). A402–A402. 1 indexed citations
16.
Parthasarathi, Gurumurthy, et al.. (2015). Impact of antidepressants use on risk of myocardial infarction: A systematic review and meta-analysis. Indian Journal of Pharmacology. 47(3). 256–256. 14 indexed citations
17.
Bansal, Dipika, Krishna Undela, Sanjay D’Cruz, & Fabrizio Schifano. (2012). Statin Use and Risk of Prostate Cancer: A Meta-Analysis of Observational Studies. PLoS ONE. 7(10). e46691–e46691. 163 indexed citations
18.
Undela, Krishna, et al.. (2012). Statin use and risk of breast cancer: a meta-analysis of observational studies. Breast Cancer Research and Treatment. 135(1). 261–269. 122 indexed citations
19.
Undela, Krishna, et al.. (2012). Statin use and risk of Parkinson’s disease: a meta-analysis of observational studies. Journal of Neurology. 260(1). 158–165. 50 indexed citations
20.
Bansal, Dipika, et al.. (2012). Type 2 diabetes and risk of prostate cancer: a meta-analysis of observational studies. Prostate Cancer and Prostatic Diseases. 16(2). 151–158. 143 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Prudence R. Carr Breakdown of academic impact, for papers by Ling Jiang Breakdown of academic impact, for papers by Iliana C. Lega Breakdown of academic impact, for papers by Fernando Martínez Martínez Breakdown of academic impact, for papers by Benjamin Daniels Breakdown of academic impact, for papers by Sean M. Ronnekleiv‐Kelly Breakdown of academic impact, for papers by Crystal N. Holick Breakdown of academic impact, for papers by John Michael Gaziano Breakdown of academic impact, for papers by Michiko Sugiyama Breakdown of academic impact, for papers by Vincenzo Favilla
Rankless by CCL
2026